EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Cooperative Release of Mitochondrial DNA From Platelets and Neutrophils Drives an Interferon Signature in Systemic Sclerosis

Stavros Giaglis iD, André N Tiaden iD, Simone Häner-Massimi, Diego Kyburz, Cedric André, Anton Glück, Enrico Ferrero, Stuart Hawtin, Tobias Junt, Ulrich A Walker

Arthritis & Rheumatology · 2026

DOI: 10.1002/art.70027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Stavros Giaglis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Experimental Rheumatology, Department of Biomedicine, University of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Scleroderma, Systemic, Blood Platelets, Neutrophils. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Mitochondria are organelles with a hypomethylated circular genome. Mitochondrial DNA (mtDNA) in the systemic circulation has been implicated in inflammation. This study investigates the role of circulating DNA in systemic sclerosis (SSc) and the cellular mechanisms governing its release.

Methods

Total DNA was isolated from the plasma of healthy controls (HCs) and patients with SSc. Copy numbers were analyzed for mtDNA (ATP‐6) and GAPDH abundance by quantitative real‐time polymerase chain reaction. mtDNA was isolated from HCs and patients with SSc. Neutrophils and platelets were incubated with the plasma and mtDNA of patients with SSc, and neutrophil extracellular trap (NET) formation was assessed by SytoxGreen and immunostainings. Platelets were tested for mtDNA release propensity. DNA oxidation was evaluated by MitoSOX Red staining in vitro and 8‐OHdG enzyme‐linked immunosorbent assay (ELISA) of patient plasma. Plasma interferon (IFN) type 1 and chemokine (C‐X‐C motif) ligand 4 (CXCL4) were measured by ELISA. IFN signaling activation capacity was evaluated using THP‐1 reporter cells and confirmed by a whole blood bulk RNA transcriptomic analysis.

Results

Median plasma mtDNA levels were 152‐fold higher in patients with SSc compared with HCs, whereas nuclear DNA levels were similar. mtDNA from SSc plasma was highly oxidized. SSc‐derived mtDNA efficiently promoted its own release by NETosis, most potently in the neutrophils of patients with SSc and by platelet activation. Oxidized mtDNA from SSc platelets in complex with CXCL4 further stimulated mtDNA release in both neutrophils and platelets. mtDNA plasma concentrations correlated with type I IFN concentrations in the blood of patients with SSc, and SSc blood exhibited elevated IFN‐stimulated gene expression. SSc plasma‐derived mtDNA‐induced IFN signaling and NET formation via endosomal Toll‐like receptors, cyclic GMP‐AMP synthase/stimulator of IFN genes, and the JAK/STAT pathway. The type I IFN pathway further promoted NETosis and mtDNA release because IFN receptor and JAK inhibition antagonized the proNETotic effects of IFN.

Conclusion

SSc plasma is characterized by highly abundant mtDNA, which drives feedback loops amplifying its own release from both neutrophils and platelets. Thus, mtDNA contributes to inflammation and tissue damage in SSc. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA, MitochondrialScleroderma, SystemicBlood PlateletsNeutrophilsInterferon Type IHumansFemaleExtracellular TrapsMiddle AgedMalePlatelet Factor 4AdultCase-Control StudiesSignal Transduction

Substanzen

DNA, MitochondrialInterferon Type IPlatelet Factor 4PF4 protein, human

Autor:innen und Institutionen

  • Laboratory for Experimental Rheumatology, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Department of Rheumatology, University Hospital Basel, Basel, Switzerland.
  • Immunology, Biomedical Research, Novartis Pharma AG, Basel, Switzerland.

ORCID-Profile: Stavros Giaglis, André N Tiaden

Förderung

  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Giaglis, S., Tiaden, A. N., Häner-Massimi, S., Kyburz, D., André, C., Glück, A., Ferrero, E., Hawtin, S., Junt, T., & Walker, U. A. (2026). A Cooperative Release of Mitochondrial DNA From Platelets and Neutrophils Drives an Interferon Signature in Systemic Sclerosis. Arthritis & Rheumatology. https://doi.org/10.1002/art.70027

Vancouver

Giaglis S, Tiaden AN, Häner-Massimi S, Kyburz D, André C, Glück A, et al. A Cooperative Release of Mitochondrial DNA From Platelets and Neutrophils Drives an Interferon Signature in Systemic Sclerosis. Arthritis & Rheumatology. 2026. doi:10.1002/art.70027

BibTeX
@article{Giaglis2026,
  author = {Giaglis, Stavros and Tiaden, André N and Häner-Massimi, Simone and Kyburz, Diego and André, Cedric and Glück, Anton and Ferrero, Enrico and Hawtin, Stuart and Junt, Tobias and Walker, Ulrich A},
  title = {A Cooperative Release of Mitochondrial DNA From Platelets and Neutrophils Drives an Interferon Signature in Systemic Sclerosis},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  doi = {10.1002/art.70027}
}
Kostenlos starten →